Advertisement
Australia markets closed
  • ALL ORDS

    8,153.70
    +80.10 (+0.99%)
     
  • ASX 200

    7,896.90
    +77.30 (+0.99%)
     
  • AUD/USD

    0.6517
    -0.0019 (-0.28%)
     
  • OIL

    83.04
    +1.69 (+2.08%)
     
  • GOLD

    2,241.90
    +29.20 (+1.32%)
     
  • Bitcoin AUD

    108,620.32
    +2,786.52 (+2.63%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • AUD/EUR

    0.6038
    +0.0007 (+0.12%)
     
  • AUD/NZD

    1.0906
    +0.0026 (+0.24%)
     
  • NZX 50

    12,105.29
    +94.63 (+0.79%)
     
  • NASDAQ

    18,254.69
    -26.15 (-0.14%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • Dow Jones

    39,807.37
    +47.29 (+0.12%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     

Medical Plastics Market to Grow at 7.7% CAGR to Hit USD 44,669.63 Million by 2027 - Impact of COVID-19 Pandemic and Global Analysis by The Insight Partners

The Medical Plastics Market Growth fuelled by rising healthcare investments in emerging economies and numerous advantages offered by plastics in medical devices; while the Asia Pacific medical plastics market is expected to grow at the highest CAGR of 8.4% during 2020–2027.

Pune, India., April 20, 2021 (GLOBE NEWSWIRE) -- Medical Plastics Market: Key Insights
According to our new research study on “Medical Plastics Market to 2027 – Global Analysis and Forecast – by Type and Application,” the Medical Plastics Market Size was valued at US$ 24,671.82 million in 2019 and is projected to reach US$ 44,669.63 million by 2027; it is expected to grow at a CAGR of 7.7% from 2020 to 2027. The stringent government regulations related to plastics used in medical devices and other related products impede the market growth.

Medical Plastics Market: Competition Landscape and Key Developments
Celanese Corporation, Eastman Chemical Company, GW Plastics, Orthoplastics Ltd, Aran Biomedical Teoranta, Rochling, SABIC, Saint-Gobain Performance Plastics, SOLVAY, and DOW are key companies operating in the global medical plastics market. These major market players are focused on strategies such as partnerships, mergers and acquisitions, facility expansions, and research and development to expand their geographic presence and customer base.

GW Plastics completed the latest expansion of its Royalton, Vermont Manufacturing and Technology Center in January 2020, in response to its growing medical device business.

ADVERTISEMENT

Solvay is supplying high-performance, medical-grade transparent film to Boeing for the production of face shields, to combat the COVID-19 pandemic. The film is manufactured by using Solvay’s medical-grade Radel PPSU or Udel PSU.

Get Exclusive Sample Pages of Medical Plastics Market - Global Analysis and Strategic Insights at https://www.theinsightpartners.com/sample/TIPRE00009963/

In 2019, North America contributed to the largest share of the global medical plastics market. With the increasing per capita health expenditure in the US, the demand for medical devices is increasing significantly, which is augmenting the growth of medical plastics market in the region. Moreover, the presence of key manufacturers such as Celanese Corporation, Dow Inc., and Eastman Chemical Co is also bolstering the market growth. Medical plastics, made from a huge number of macromolecules, are used to produce consistent and safe instruments for the healthcare sector, as they are remarkably long-lasting, supple, and economical. The performance, sterility, and quality of tools made from medical plastic is a major factor boosting their demand. The plastics are used to produce diagnostic instruments, implants and prosthetics, disposables, drug delivery devices, surgical instruments, syringes, and catheters because of their low weight, high performance, and lower costs.

With the increasing population and rising geriatric population, diseases and infections are rampantly spreading through several mediums. According to a report by the US Department of Health and Human Services, ~8.7 million sports and recreation injuries were reported in the country in 2018. Out of these, 72% were injuries associated with upper and lower extremities. The increasing number of such injuries is boosting the demands for prosthetics products, further propelling the medical plastics market growth. Based on type, the medical plastics market is segmented into standard plastics, engineering, plastics, high performance plastic (HPP), silicone, and others. The standard plastic segment led the medical plastic market with a share of 32.2% in 2019. By application, the medical plastic market is segmented into medical disposables, prosthetics, medical instruments and tools, drug delivery, and others. The medical instruments and tools segment led the market with a share of 33.6% in 2019.

Download Sample PDF Brochure of Medical Plastics Market Research Report at https://www.theinsightpartners.com/sample/TIPRE00009963/

The increasing disposable income and rapid urbanization are fueling the demand for advanced healthcare services and treatments in emerging economies. In addition to the rising geriatric population, growing preference for modern healthcare services from urban middle-class population is leading to high consumer spending on healthcare. According to the United Nations, the percentage of population comprising people aged 65 and above in emerging countries would rise by 10–15% of the overall population by 2030. In addition, factors such as increasing GDP, expanding middle class, rising life expectancy, and growing disposable income are boosting the demand for medical devices across emerging economies in Asia. Thus, the surge in demand for medical devices eventually leads to the medical plastics market growth.

Medical Plastics Market: Segmental Overview
Based on type, the medical plastics market is segmented into standard plastics, engineering, plastics, high performance plastic (HPP), silicone, and others; the standard plastic segment led the market with a share of 32.2% in 2019. Polyvinyl chloride, polyolefin, polyethylene, polypropylene, polystyrene, and poly (methyl methacrylate) are among the types considered under standard plastic segment. These materials must be processed and manufactured under a physician’s license to pass validation requirements and verification of the regulatory bodies. Growing application scope for standard plastics in the manufacturing of diagnostic devices, pans, trays, containers, syringes, implant trials, and medical cover sheets is contributing to the market the growth of this segment.

By application, the medical plastic market is segmented into medical disposables, prosthetics, medical instruments and tools, drug delivery, and others. The medical instruments and tools segment led the market with a share of 33.6% in 2019. Plastics have been used extensively to create medical tools and medical instruments such as syringes, surgical gloves, insulin pens, catheters, IV tubes, and inflatable splits. Such products are manufactured for one-time use, which helps avoid the spread of dangerous diseases. Plastic is also being used to create superior antimicrobial touch surfaces, which do not allow the adherence of microbes and other bacteria to the surfaces. Disposable plastic syringes, new heart valves, blood bags, and other medical devices are being manufactured using plastics. Moreover, high-purity plastics are utilized in medical devices including surgical instruments, dental instruments, anesthetic, diagnostic, endoscopic probes, and imaging equipment.

Buy Copy of Medical Plastics Market Research Study at https://www.theinsightpartners.com/buy/TIPRE00009963/

Impact of COVID-19 Pandemic on Medical Plastics Market
COVID-19 first began in Wuhan (China) in December 2019 and since then it has spread across the globe. As of April 2021, the US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The COVID-19 pandemic has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The global chemical and materials industry is one of the major industries suffering serious disruptions such as supply chain breaks, technology event cancellations, and office shutdowns because of this outbreak. For instance, US is the global hub of manufacturing and the significant consumer of various chemicals & materials. It is one of the worst affected countries. The lockdown of various plants and factories in the country has affected the global supply chains and manufacturing, delivery schedules, and sales of various chemicals and materials. Various companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe and Asia, are affecting the business collaborations and partnership opportunities. All these factors are anticipated to affect the chemical and materials industry in a negative manner, and thus, act as restraining factor for the growth of various markets related to this industry in the coming months.




About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

Press Release - https://www.theinsightpartners.com/pr/medical-plastics-market